Article
Single-cell level characterization of B cell depletion and repopulation following rituximab in systemic lupus erythematosus
2025-05-28
Abstract excerpt
<h4>Objective</h4> Rituximab, a CD20 + B cell depletion therapy, is frequently used in the treatment of systemic lupus erythematosus (SLE). However, variability in patient response highlights the need for a deeper understanding of the underlying immune cell dynamics of B cell depletion and repopulation. <h4>Methods</h4> In this study, we conducted longitudinal single-cell profiling of nine SLE patients treated wit...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c4f33878-eb94-5ffa-a6dd-5c3601c94964
- DOI
- 10.1101/2025.05.27.25328230
